Western Financial Corp CA Has $1.58 Million Stock Holdings in Axon Enterprise, Inc $AXON

Western Financial Corp CA raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 147.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,203 shares of the biotechnology company’s stock after buying an additional 1,311 shares during the period. Western Financial Corp CA’s holdings in Axon Enterprise were worth $1,581,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Hemington Wealth Management raised its holdings in shares of Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 17 shares in the last quarter. Whipplewood Advisors LLC increased its position in Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the last quarter. Darwin Wealth Management LLC acquired a new position in Axon Enterprise in the 2nd quarter worth about $37,000. NewSquare Capital LLC lifted its holdings in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after buying an additional 25 shares during the last quarter. Finally, Washington Trust Advisors Inc. grew its stake in shares of Axon Enterprise by 44.7% in the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock valued at $46,000 after buying an additional 17 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on AXON shares. Barclays cut their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating on the stock in a research report on Thursday, November 6th. Wall Street Zen downgraded shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Royal Bank Of Canada began coverage on shares of Axon Enterprise in a research note on Monday, November 17th. They issued an “outperform” rating and a $860.00 price objective for the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Finally, UBS Group lowered their target price on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $802.71.

Insiders Place Their Bets

In other Axon Enterprise news, CFO Brittany Bagley sold 2,500 shares of Axon Enterprise stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $610.00, for a total value of $1,525,000.00. Following the transaction, the chief financial officer directly owned 91,092 shares of the company’s stock, valued at $55,566,120. The trade was a 2.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $551.92, for a total value of $5,519,200.00. Following the transaction, the chief executive officer owned 3,110,997 shares of the company’s stock, valued at approximately $1,717,021,464.24. This trade represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 60,540 shares of company stock valued at $35,632,038 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Price Performance

NASDAQ AXON opened at $563.45 on Friday. Axon Enterprise, Inc has a 1 year low of $469.24 and a 1 year high of $885.91. The company has a fifty day simple moving average of $585.88 and a 200 day simple moving average of $693.75. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The company has a market cap of $44.46 billion, a P/E ratio of 178.31, a P/E/G ratio of 17.74 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm had revenue of $710.64 million during the quarter, compared to the consensus estimate of $704.83 million. During the same quarter last year, the business earned $1.45 EPS. The business’s revenue was up 30.6% compared to the same quarter last year. On average, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.